ORCL / Company research
Oracle earnings and filings
Financial results, original SEC reports and source-linked quarterly highlights.
SEC EDGAR / Collected
Latest available quarterly financial highlights
-
Revenue: $19.35 billion for the quarter from 2026-06-01 to 2026-08-31. Revenue changed +29.6% from the comparable prior-year quarter.
-
Operating income / loss: $6.73 billion for the quarter from 2026-06-01 to 2026-08-31.
-
Net income / loss: $4.76 billion for the quarter from 2026-06-01 to 2026-08-31.
-
Diluted EPS: $1.56 for the quarter from 2026-06-01 to 2026-08-31.
Highlights are calculated from supported SEC financial facts, not investment recommendations or analyst estimates. Later filings may restate prior results. A newer announcement can precede the availability of structured financial facts.
Reports and results announcements
An 8-K marked Item 2.02 announces results; the earnings release or presentation may be an exhibit under “All exhibits and attachments.” Filings are official source documents, not an audit performed by this publication.
ORCL annual investment, R&D and cash flow
Quarterly highlights and original SEC reports
Verified annual USD facts from SEC filings. Collected .
| Annual period | Revenue | Cash capex | Productive asset purchases | Operating cash flow | Free cash flow | R&D | R&D / revenue |
|---|---|---|---|---|---|---|---|
| to | $67.36 billion | $55.66 billion | Not available | $31.98 billion | -$23.69 billion | $10.27 billion | 15.3% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001193125-26-277521
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001193125-26-277521
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001193125-26-277521
ResearchAndDevelopmentExpense · 10-K filed · accession 0001193125-26-277521
|
|||||||
| to | $57.4 billion | $21.22 billion | Not available | $20.82 billion | -$394 million | $9.86 billion | 17.2% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001193125-26-277521
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001193125-26-277521
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001193125-26-277521
ResearchAndDevelopmentExpense · 10-K filed · accession 0001193125-26-277521
|
|||||||
| to | $52.96 billion | $6.87 billion | Not available | $18.67 billion | $11.81 billion | $8.92 billion | 16.8% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001193125-26-277521
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001193125-26-277521
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001193125-26-277521
ResearchAndDevelopmentExpense · 10-K filed · accession 0001193125-26-277521
|
|||||||
| to | $49.95 billion | $8.7 billion | Not available | $17.17 billion | $8.47 billion | $8.62 billion | 17.3% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0000950170-25-087926
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0000950170-25-087926
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0000950170-25-087926
ResearchAndDevelopmentExpense · 10-K filed · accession 0000950170-25-087926
|
|||||||
SEC filing data: definitions, coverage and revisions
Source: the SEC Company Facts API, using standard US GAAP facts in USD from annual 10-K, 20-F or 40-F filings and amendments. Periods must span 300-400 days. Quarterly and year-to-date values are not presented as annual totals.
- Cash capex is cash payments to acquire property, plant and equipment. It excludes broader acquisition or intangible-asset tags and is not total AI spending or an estimate of finance-lease investment.
- Productive asset purchases are a separately reported, broader cash investment measure. They are shown in their own column and never substituted into PP&E capex, capital intensity or free cash flow. Do not rank mixed definitions as if they were identical.
- Free cash flow here is operating cash flow minus cash capex. It may differ from a company's adjusted free cash flow definition. If either input is missing, the result is omitted.
- R&D intensity is reported research and development expense divided by revenue from the same annual reporting period. Operating cash margin and capital intensity use the same-period revenue denominator.
- Figures are company-wide, not AI-specific or segment-level. Financial years differ, so compare the displayed start and end dates rather than assuming calendar-year alignment.
- The latest available filing for each supported fact is used, including restated comparative figures. Conflicting values from equally recent reports are omitted. Every figure retains its XBRL tag, accession and filing date.
Company-specific extension tags, IFRS-only data and unsupported definitions are not estimated. Missing standard facts are shown as unavailable, not zero. Data is refreshed in the background; the collection time is separate from the filing date.
Source: SEC EDGAR. Company-specific segment metrics and unsupported accounting tags are not estimated.